e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Novel insights from in vitro and in vivo models of lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Development of papain-induced asthma-COPD overlap mice model
K. Fukuda (Tokyo, Japan), H. Matsuzaki (Tokyo, Japan), Y. Hiraishi (Tokyo, Japan), Y. Mikami (Tokyo, Japan), K. Makita (Tokyo, Japan), T. Nagase (Tokyo, Japan)
Source:
International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease
Session:
Novel insights from in vitro and in vivo models of lung disease
Session type:
Thematic Poster
Number:
4070
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Fukuda (Tokyo, Japan), H. Matsuzaki (Tokyo, Japan), Y. Hiraishi (Tokyo, Japan), Y. Mikami (Tokyo, Japan), K. Makita (Tokyo, Japan), T. Nagase (Tokyo, Japan). Development of papain-induced asthma-COPD overlap mice model. 4070
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Allergen-induced inflammation and airway responsiveness in a mouse model of asthma: comparison between C57BL/6 and Th2-prone BALB/c mice
Source: Eur Respir J 2003; 22: Suppl. 45, 484s
Year: 2003
Establishment of an experimental BALB/c mouse model for studies on isocyanate asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 587s
Year: 2005
Development of a mouse model of airway inflammation and remodeling in experimental asthma
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007
Autoimmune induction of a COPD-like inflammatory phenotype in mice
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Value of genetically modified mice as models of asthma and allergy
Source: Annual Congress 2007 - PG11 - Translation of animal models to human airway disease
Year: 2007
The effect of lipopolysaccharide-contaminated ovalbumin on airway inflammation and remodeling in a chronic murine asthma model
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
Mapping a mouse model of severe asthma to human asthma using gene set variation analysis
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015
Longitudinal imaging characterisation of a model of chronic allergic lung inflammation in mice
Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life
Year: 2012
Stability of reference genes in five C57/Bl6 models of lung inflammation
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
Models of asthma employing ovalbumin in rats and mice: similarities and differences compared with patient asthma
Source: Annual Congress 2005 - PG11 - Experimental models for COPD and asthma
Year: 2005
HDM-challenged mice exhibit impaired interferon response to TLR3 ligand in a murine model of viral asthma exacerbation
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
IL33 and TSLP involvements in influenza-induced exacerbation in a murine model of chronic asthma
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015
Improving of experimental allergic asthma by decreased Th2 responses in OGR-1 knockout mice
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Genetic analysis of antigen-induced airway manifestations of asthma using recombinant congenic mouse strains
Source: Eur Respir J 2003; 22: Suppl. 45, 484s
Year: 2003
BmTI-A: A serine protease inhibitor attenuates hyperresponsiveness in an experimental model of chronic allergic inflammation in Balb/c mice
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Intratracheal challenged mice asthma model: can pure low airways inflammation influence the nose?
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Establishment of a murine asthma exacerbation model by combining OVA exposure with either RSV or influenza infection
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
The effect of anti-IL-33 antibody and soluble ST2 in a murine model of allergic asthma
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
Development of IL-33-induced asthmatic airway inflammation in human IL-3/GM-CSF/IL-5-transgenic NOG mice
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017
Effects of acute hypochlorite exposure in OVA-sensitized and challenged mice
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept